| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Cheng,Zheng-Yu | Chairman | 40.66% | Formosa Laboratories, Inc. |
| Huang,Wen-Hong | Director | 40.66% | Formosa Laboratories, Inc. |
| Ma,Hai-Yi | Director | 0.36% | |
| Zhang,Hong-Ren | Director | 0.00% | |
| Kang,Zhao-Zhou | Independent Director | 0.00% | |
| Su,Yu-Hui | Independent Director | 0.00% | |
| Luo,Li-Zhu | Independent Director | 0.00% |
Change Capital to 2,000,000,000
2021/05/03
Change Capital to 1,200,000,000
2020/06/12
Change Capital to 1,000,000,000
2019/08/12
Change Capital to 800,000,000
2017/12/20
Change Capital to 349,208,000
2017/08/24
Change Capital to 198,000,000
2017/06/07
Change Capital to 158,000,000
2016/09/19
Change Capital to 120,000,000
2014/12/02
Change Capital to 85,000,000
2013/02/01
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 594 | 143,356 | 31,172 |
| Operating cost | 1,260 | 24,366 | 3,825 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | -666 | 118,990 | 27,347 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | -666 | 118,990 | 27,347 |
| Operating expenses | 34,247 | 294,619 | 310,383 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -34,913 | -175,629 | -283,036 |
| Non-operating income and expenses | -6,001 | -3,945 | -17,029 |
| Net profit (loss) before tax | -40,914 | -179,574 | -300,065 |
| Income tax expense (benefits) | -123 | 21,359 | 21,862 |
| Net profit (loss) of ongoing business for the current period | -40,791 | -200,933 | -321,927 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -40,791 | -200,933 | -321,927 |
| Other comprehensive profit (loss), net | 1,713 | -57,715 | -11,824 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -39,078 | -258,648 | -333,751 |
| Net profit (loss) attributable to owners of parent company | -40,745 | -201,014 | -321,956 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -46 | 81 | 29 |
| Comprehensive profit (loss) attributable to owners of parent company | -39,081 | -258,701 | -333,726 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 3 | 53 | -25 |
| Basic earnings per share (yuan) | 0 | -1 | -2 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -76,913 | -128,682 | -196,038 |
| Net cash inflows (outflows) from investing activities | -119,380 | -475,292 | -676,214 |
| Net cash inflow (outflow) from financing activities | -1,404 | 624,402 | 999,877 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 36,641 | 20,652 | -10,258 |
| Increase (decrease) in cash and cash equivalents in the current period | -161,056 | 41,080 | 117,367 |
| Beginning balance of cash and cash equivalents | 425,785 | 384,705 | 267,338 |
| Ending balance of cash and cash equivalents | 264,729 | 425,785 | 384,705 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,681,578 | 1,727,790 | 1,288,330 |
| Non-current asset | 378,124 | 384,482 | 438,451 |
| Total asset | 2,059,702 | 2,112,272 | 1,726,781 |
| Current liability | 200,509 | 197,951 | 257,979 |
| Non-current liability | 349,475 | 365,749 | 328,232 |
| Total liability | 549,984 | 563,700 | 586,211 |
| share capital | 1,509,771 | 1,509,771 | 1,341,421 |
| Equity - secruity token | - | - | - |
| capital reserve | 2,278,962 | 2,278,738 | 1,780,438 |
| retained earning | -2,193,684 | -2,152,937 | -1,951,923 |
| Other equity | -85,928 | -87,594 | -29,907 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,509,121 | 1,547,978 | 1,140,029 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 597 | 594 | 541 |
| Total Equity | 1,509,718 | 1,548,572 | 1,140,570 |
| Share capital awaiting retirement (unit: share) | - | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 10 | 10 | 8 |
